CWHM-12
CAS No. 1564286-55-0
CWHM-12 ( CWHM12; CWHM 12; CWHM-12. )
Catalog No. M12231 CAS No. 1564286-55-0
A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 43 | Get Quote |
|
5MG | 72 | Get Quote |
|
10MG | 115 | Get Quote |
|
25MG | 210 | Get Quote |
|
50MG | 350 | Get Quote |
|
100MG | 521 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCWHM-12
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).
-
DescriptionA novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM); significantly inhibits progression of pulmonary fibrosis in mice model.Cystic Fibrosis Preclinical
-
SynonymsCWHM12; CWHM 12; CWHM-12.
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaOther Indications
-
IndicationFibrosis
Chemical Information
-
CAS Number1564286-55-0
-
Formula Weight590.47
-
Molecular FormulaC26H32BrN5O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10.5 mg/mL
-
SMILESOC1=CC(C(NCC(N[C@@H](CC(O)=O)C2=CC(Br)=CC(C(C)(C)C)=C2)=O)=O)=CC(NC3=NCC(O)CN3)=C1
-
Chemical Nameβ-Alanine, N-[3-hydroxy-5-[(1,4,5,6-tetrahydro-5-hydroxy-2-pyrimidinyl)amino]benzoyl]glycyl-3-[3-bromo-5-(1,1-dimethylethyl)phenyl]-, (3S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Henderson NC, et al. Nat Med. 2013 Dec;19(12):1617-24.
2. Ulmasov B, et al. Cell Mol Gastroenterol Hepatol. 2016 Mar 16;2(4):499-518.
2. Ulmasov B, et al. Cell Mol Gastroenterol Hepatol. 2016 Mar 16;2(4):499-518.
molnova catalog
related products
-
OSU-T315
A novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM.
-
Arg-Gly-Asp TFA
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion addresses certain cell lines and elicits specific cell responses; binds to?integrins.
-
Vedolizumab
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.